143 related articles for article (PubMed ID: 17199917)
1. [Effect of triptorelin and an extended-interval dosing regimen in the treatment of patients with endometriosis and adenomyoma].
Liu DY; Gu MJ; Shu JZ; Shi YX; Wang CY; Han ZQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):656-9. PubMed ID: 17199917
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
3. Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study.
Tse CY; Chow AM; Chan SC
Hong Kong Med J; 2000 Sep; 6(3):260-4. PubMed ID: 11025843
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial on the effectiveness and safety of triptorelin in treatment of uterine leiomyoma].
Zhou YF; Yang DZ; Hu LN; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):460-3. PubMed ID: 16080872
[TBL] [Abstract][Full Text] [Related]
5. Long-acting triptorelin for the treatment of endometriosis.
Choktanasiri W; Boonkasemsanti W; Sittisomwong T; Kunathikom S; Suksompong S; Udomsubpayakul U; Rojanasakul A
Int J Gynaecol Obstet; 1996 Sep; 54(3):237-43. PubMed ID: 8889631
[TBL] [Abstract][Full Text] [Related]
6. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and lipid profile in patients with endometriosis treated by GnRH agonist.
Al-Omari WR; Nassir UN; Sulaiman WR
Int J Gynaecol Obstet; 1999 Aug; 66(2):191-2. PubMed ID: 10468351
[No Abstract] [Full Text] [Related]
8. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
Li X; Li H; Shi H; Li X; Zhou R; Lu D; Cai Y; Zhou Y; Cabri P; Shi X; Pedret-Dunn A; Leng J
Adv Ther; 2022 Oct; 39(10):4663-4677. PubMed ID: 35947347
[TBL] [Abstract][Full Text] [Related]
10. [Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa].
Palatyński A; Gruszczyńska J
Ginekol Pol; 2001 May; 72(5):290-5. PubMed ID: 11526759
[TBL] [Abstract][Full Text] [Related]
11. A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.
Cirkel U; Ochs H; Schneider HP
Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):61-9. PubMed ID: 7781864
[TBL] [Abstract][Full Text] [Related]
12. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
[TBL] [Abstract][Full Text] [Related]
13. Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia.
Andreeva E; Absatarova Y
Int J Gynaecol Obstet; 2020 Dec; 151(3):347-354. PubMed ID: 32815156
[TBL] [Abstract][Full Text] [Related]
14. Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?
Vercellini P; Bandini V; Buggio L; Barbara G; Berlanda N; Dridi D; Frattaruolo MP; Somigliana E
Hum Reprod Open; 2023; 2023(2):hoad008. PubMed ID: 37016694
[TBL] [Abstract][Full Text] [Related]
15. [Application of half-dose depot long-acting triptorelin in postoperative adjuvant therapy for endometriosis].
Liu X; Zhang HX; Wang LP; Fu WP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):208-11. PubMed ID: 23570596
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
17. Triptorelin for the treatment of endometriosis.
Leone Roberti Maggiore U; Scala C; Remorgida V; Venturini PL; Del Deo F; Torella M; Colacurci N; Salvatore S; Ferrari S; Papaleo E; Candiani M; Ferrero S
Expert Opin Pharmacother; 2014 Jun; 15(8):1153-79. PubMed ID: 24832495
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
[TBL] [Abstract][Full Text] [Related]
19. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
[TBL] [Abstract][Full Text] [Related]
20. Triptorelin improves intestinal symptoms among patients with colorectal endometriosis.
Ferrero S; Camerini G; Ragni N; Menada MV; Venturini PL; Remorgida V
Int J Gynaecol Obstet; 2010 Mar; 108(3):250-1. PubMed ID: 19944420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
